LY2365109 hydrochloride is a potent and selective GlyT1 inhibitor used to elevate cerebrospinal fluid (CSF) glycine levels in a dose-dependent manner; it increases seizure threshold in mice and is employed in research related to glycine transporter (GlyT1) modulation and neurological disorders such as seizures.